Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors
Kirsten McAulay, Emily Hoyt, Morgan Thomas, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 23, pp. 10358-10372
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
Haixia Su, Sheng Yao, Wenfeng Zhao, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 162
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo A. M. Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 49
10 Years Into the Resurgence of Covalent Drugs
Elena De Vita
Future Medicinal Chemistry (2020) Vol. 13, Iss. 2, pp. 193-210
Open Access | Times Cited: 100
Discovery of Cysteine-targeting Covalent Protein Kinase Inhibitors
Xiaoyun Lu, Jeff B. Smaill, Adam V. Patterson, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 1, pp. 58-83
Closed Access | Times Cited: 90
Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy
Adileh Ayati, Setareh Moghimi, Mahsa Toolabi, et al.
European Journal of Medicinal Chemistry (2021) Vol. 221, pp. 113523-113523
Closed Access | Times Cited: 83
Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry
Rambabu Reddi, Efrat Resnick, Adi Rogel, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 13, pp. 4979-4992
Open Access | Times Cited: 71
Recent advances in the development of covalent inhibitors
Hyunsoo Kim, Yoon Soo Hwang, Mingi Kim, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 7, pp. 1037-1045
Open Access | Times Cited: 64
Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development
Fangjiao Huang, Xiaoli Han, Xiaohui Xiao, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7728-7728
Open Access | Times Cited: 60
Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study
Manar G. Salem, Dina M. Abu El-Maaty, Yassmina I. Mohey El-Deen, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4898-4898
Open Access | Times Cited: 40
Exploring the Versatility of the Covalent Thiol–Alkyne Reaction with Substituted Propargyl Warheads: A Deciding Role for the Cysteine Protease
Elma Mons, Robbert Q. Kim, Bjorn R. van Doodewaerd, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 17, pp. 6423-6433
Open Access | Times Cited: 55
Recent progress in covalent warheads for in vivo targeting of endogenous proteins
Naoya Shindo, Akio Ojida
Bioorganic & Medicinal Chemistry (2021) Vol. 47, pp. 116386-116386
Open Access | Times Cited: 44
The expanding repertoire of covalent warheads for drug discovery
Namrashee V. Mehta, Mariam S. Degani
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103799-103799
Closed Access | Times Cited: 21
Covalent hits and where to find them
Simon C. C. Lucas, J. Henry Blackwell, Sarah H. Hewitt, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100142-100142
Open Access | Times Cited: 7
Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies
Marwa A. Fouad, Alaa A. Osman, Noha M. Abdelhamid, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 6
Synthesis of N-CF3 Alkynamides and Derivatives Enabled by Ni-Catalyzed Alkynylation of N-CF3 Carbamoyl Fluorides
Christian D.‐T. Nielsen, Filip G. Zivkovic, Franziska Schoenebeck
Journal of the American Chemical Society (2021) Vol. 143, Iss. 33, pp. 13029-13033
Closed Access | Times Cited: 40
Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis
Endri Karaj, Shaimaa H. Sindi, Nishanth Kuganesan, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11788-11817
Open Access | Times Cited: 26
Covalent chemical probes for protein kinases
Ricardo A. M. Serafim, Lisa Haarer, Júlia G. B. Pedreira, et al.
Current Research in Chemical Biology (2023) Vol. 3, pp. 100040-100040
Open Access | Times Cited: 16
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
Kirsten McAulay, Alan Bilsland, Marta Bon
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 22
Ynamide Electrophile for the Profiling of Ligandable Carboxyl Residues in Live Cells and the Development of New Covalent Inhibitors
Shengrong Li, Pengwei Zhang, Fang Xu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10408-10418
Closed Access | Times Cited: 20
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GIST
Tom Schulz, Rajesh Gontla, Alina Teuber, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Development and application of novel electrophilic warheads in target identification and drug discovery
Yue Liu, Shumin Lv, Lijie Peng, et al.
Biochemical Pharmacology (2021) Vol. 190, pp. 114636-114636
Closed Access | Times Cited: 27
Access to N‐Monofluoromethylated (Thio)Carbamates, Formamides, Alkynamides and Related Derivatives
Filip G. Zivkovic, Fritz Bahns, Che-Ming Hsu, et al.
Angewandte Chemie International Edition (2025)
Closed Access
Electrophilic MiniFrags Revealed Unprecedented Binding Sites for Covalent HDAC8 Inhibitors
Aaron Keeley, Aleksandra Kopranovic, V. di Lorenzo, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 572-585
Open Access | Times Cited: 9
Advanced approaches of developing targeted covalent drugs
Conghao Gai, Suzannah J. Harnor, Shihao Zhang, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 12, pp. 1460-1475
Open Access | Times Cited: 14
Discovery of Non-Cysteine-Targeting Covalent Inhibitors by Activity-Based Proteomic Screening with a Cysteine-Reactive Probe
Ye‐Jin Jung, Naotaka Noda, Junichiro Takaya, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 2, pp. 340-347
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top